← Back to Patent Explorer
US4545987A Expired / Lapsed US ⏱️ 0.0 years remaining

Psoralen inactivated double-stranded RNA viral vaccines

Assignee: Bayer Corp
•
Filing: 1983-12-20
•
Granted: 1985-10-08
•
Expires: 2003-12-20
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Novel vaccines of double-stranded RNA viruses are prepared by psoralen inactivation under mild conditions in an inert atmosphere, optionally in the presence of a mild singlet oxygen scavenger. The resulting inactivated virus can be used as a vaccine for inoculation of hosts to provide for the stimulation of the immune system to the virus.

Inventors

  • 👤 Richard E. Giles
  • 👤 David R. Stevens
  • 👤 Gary P. Wiesehahn

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-25 21:39
CPC Classifications
C; C12; C12N; C12N7/00; A; A61; A61K; A61K39/00; A61K39/12; A61K39/15; A61K2039/51; A61K2039/525; A61K2039/5252; A61K2039/545; A61K2039/555; A61K2039/55505; A61K2039/55511; A61K2039/55566; C12N2720/00; C12N2720/00011; C12N2720/12011; C12N2720/12111; C12N2720/12134; C12N2720/12161; C12N2720/12163; Y; Y10; Y10S; Y10S424/00; Y10S424/813; Y10S424/814

Claims Analysis

Total Claims: 17
Claim 1
Independent Claim 79 words
A vaccine useful for inoculation of a mammalian host susceptible to infection by Bluetongue virus (BTV), which comprises at least one furocoumarin-inactivated BTV serotype in from about 10 6 to 10 9 pfu/ml, wherein said inactivation is as a result of irradiation of BTV in the presence of an inactivating furocoumarin with long wavelength ultraviolet light at a temperature below about 40° C. for a time sufficient to inactivate said BTV to a non-infectious degree, and an immunologic adjuvant.
Claim 2
Dependent Claim 79 words
A vaccine useful for inoculation of a mammalian host susceptible to infection by Bluetongue virus (BTV), which comprises at least one furocoumarin-inactivated BTV serotype in from about 10 6 to 10 9 pfu/ml, wherein said inactivation is as a result of irradiation of BTV in the presence of an inactivating furocoumarin with long wavelength ultraviolet light at a temperature below about 40° C. for a time sufficient to inactivate said BTV to a non-infectious degree, and an immunologic adjuvant.
Claim 3
Dependent Claim 11 words
A vaccine according to claim 1, wherein said furocoumarin is 4'-aminomethyl-4,5',8-trimethylpsoralen.
Claim 4
Dependent Claim 13 words
A vaccine according to claim 2, wherein said BTV is of serotype 11.
Claim 5
Dependent Claim 19 words
A vaccine according to claim 1, wherein said BTV is inactivated in the presence of a singlet oxygen scavenger.
Claim 6
Dependent Claim 17 words
A vaccine according to claim 1, wherein said inactivation is performed in the substantial absence of oxygen.
Claim 7
Dependent Claim 21 words
A vaccine according to claim 1, wherein said BTV is grown in substantially confluent monolayers of cells immediately prior to inactivation.
Claim 8
Dependent Claim 73 words
A vaccine useful for inoculation of a mammalian host susceptible to infection by Bluetongue virus (BTV), which comprises BTV serotype 11 inactivated with 4'-aminomethyl-4,5',8-trimethylpsoralen by irradiation with long wavelength ultraviolet light at a temperature in the range of about -10° to 25° C. for a time sufficient to inactivate said BTV to become non-infectious, said BTV being present in an amount of about 10 6 to 10 9 pfu/ml, and an immunologic adjuvant.
Claim 9
Dependent Claim 73 words
A vaccine useful for inoculation of a mammalian host susceptible to infection by Bluetongue virus (BTV), which comprises BTV serotype 11 inactivated with 4'-aminomethyl-4,5',8-trimethylpsoralen by irradiation with long wavelength ultraviolet light at a temperature in the range of about -10° to 25° C. for a time sufficient to inactivate said BTV to become non-infectious, said BTV being present in an amount of about 10 6 to 10 9 pfu/ml, and an immunologic adjuvant.
Claim 10
Dependent Claim 75 words
A vaccine useful for inoculation of a mammalian host susceptible to infection by Bluetongue virus (BTV), which comprises at least one furocoumarin-inactivated BTV serotype in from about 10 6 to 10 9 pfu/ml, wherein said inactivation is as a result of irradiation of BTV in the presence of an inactivating furocoumarin with long wavelength ultraviolet light at a temperature below about 40° C. for a time sufficient to inactivate said BTV to a non-infectious degree.
Claim 11
Dependent Claim 75 words
A vaccine useful for inoculation of a mammalian host susceptible to infection by Bluetongue virus (BTV), which comprises at least one furocoumarin-inactivated BTV serotype in from about 10 6 to 10 9 pfu/ml, wherein said inactivation is as a result of irradiation of BTV in the presence of an inactivating furocoumarin with long wavelength ultraviolet light at a temperature below about 40° C. for a time sufficient to inactivate said BTV to a non-infectious degree.
Claim 12
Dependent Claim 60 words
A vaccine useful for inoculation of a mammalian host susceptible to infection by Bluetongue virus (BTV), which comprises BTV serotype 11 inactivated with 4'-aminomethyl-4,5',8-trimethylpsoralen by temperature in the range of about -10° to 25° C. for a time sufficient to inactivate said BTV to become non-infectious, said BTV being present in an amount of 10 6 to 10 9 pfu/ml.
Claim 13
Dependent Claim 60 words
A vaccine useful for inoculation of a mammalian host susceptible to infection by Bluetongue virus (BTV), which comprises BTV serotype 11 inactivated with 4'-aminomethyl-4,5',8-trimethylpsoralen by temperature in the range of about -10° to 25° C. for a time sufficient to inactivate said BTV to become non-infectious, said BTV being present in an amount of 10 6 to 10 9 pfu/ml.
Claim 14
Independent Claim 69 words
A method for producing a vaccine for inoculation of a mammalian host susceptible to infection by bluetongue virus (BTV), which method comprises inactivating at least one BTV serotype by exposure to long wavelength ultraviolet light in the presence of a furocoumarin at a temperature below about 40° C. for a time sufficient to inactivate said BTV to a non-infectious degree, and combining said inactivated BTV with an appropriate adjuvent.
Claim 15
Independent Claim 69 words
A method for producing a vaccine for inoculation of a mammalian host susceptible to infection by bluetongue virus (BTV), which method comprises inactivating at least one BTV serotype by exposure to long wavelength ultraviolet light in the presence of a furocoumarin at a temperature below about 40° C. for a time sufficient to inactivate said BTV to a non-infectious degree, and combining said inactivated BTV with an appropriate adjuvent.
Claim 16
Independent Claim 74 words
A method for producing a vaccine for inoculation of a mammalian host susceptible to infection by bluetongue virus (BTV), which method comprises exposure of at least one BTV serotype to long wavelength ultraviolet light in the presence of 4'-aminomethyl-4,5', 8-trimethylpsoralen at a temperature in the range from about -10° C. to 25° C. for a time sufficient to inactivate the BTV to a non-infectious degree, and combining said inactivated BTV with a suitable adjuvant.
Claim 17
Independent Claim 74 words
A method for producing a vaccine for inoculation of a mammalian host susceptible to infection by bluetongue virus (BTV), which method comprises exposure of at least one BTV serotype to long wavelength ultraviolet light in the presence of 4'-aminomethyl-4,5', 8-trimethylpsoralen at a temperature in the range from about -10° C. to 25° C. for a time sufficient to inactivate the BTV to a non-infectious degree, and combining said inactivated BTV with a suitable adjuvant.

References Cited (Backward Citations)

No citation records indexed.

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1988-10-07 1989-04-08 1989-10-08 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1992-10-07 1993-04-08 1993-10-08 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1996-10-07 1997-04-08 1997-10-08 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag